Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment...

Area of Science:

• Nephrology
• Endocrinology
• Cardiovascular Science

Background:

• Type 1 diabetes poses significant risks for kidney complications.
• Inflammation and endothelial dysfunction are implicated in diabetic kidney disease pathogenesis.
• Longitudinal data on specific biomarker associations with kidney dysfunction progression are crucial.

Purpose of the Study:

• To investigate the association between inflammation, endothelial dysfunction, and clotting/fibrinolysis biomarkers and the development of kidney dysfunction in type 1 diabetes.
• To determine the time frame over which these associations persist.

Main Methods:

• Analysis of the DCCT/EDIC cohort over 28 years.
• Measurement of multiple biomarkers including C-reactive protein, fibrinogen, IL-6, sTNFR-1/2, sICAM-1, sVCAM-1, sE-selectin, and PAI-1.
• Definition of renal outcomes as chronic kidney disease (stage 3+) or macroalbuminuria.
• Prospective multivariate event-time analyses with 3-year and 10-year windows.

Main Results:

• Several inflammation (sTNFR-1/2), endothelial dysfunction (sE-selectin), and clotting/fibrinolysis (fibrinogen, PAI-1) biomarkers were significantly associated with subsequent kidney dysfunction.
• These associations were consistent across both 3-year and 10-year follow-up periods.
• Biomarkers like sTNFR-1/2, sE-selectin, PAI-1, and fibrinogen showed sustained predictive value for chronic kidney disease progression.

Conclusions:

• Plasma markers of inflammation, endothelial dysfunction, and clotting/fibrinolysis are linked to kidney dysfunction progression in type 1 diabetes.
• These associations are evident in both short-term and long-term follow-up periods.
• The findings highlight the role of these pathways in the development and progression of diabetic kidney disease.